Protalix BioTherapeutics Inc(PLX)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

PLX Protalix BioTherapeutics Inc

休市中 04-26 16:00:00 EDT

1.15

-0.03

-2.54%

盘后1.15

+0.000.00%

16:20 EDT

最高1.22	最低1.09	成交量95.87万
今开1.19	昨收1.18	日振幅11.02%
总市值8,401万	流通市值7,416万	总股本7,305万
成交额107.85万	换手率1.49%	流通股本6,448万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"PLX","market":"US","secType":"STK","nameCN":"Protalix BioTherapeutics Inc","latestPrice":1.15,"timestamp":1714161600000,"preClose":1.18,"halted":0,"volume":958735,"hourTrading":{"tag":"盘后","latestPrice":1.15,"preClose":1.15,"latestTime":"16:20 EDT","volume":5179,"amount":5955.85,"timestamp":1714162800887},"delay":0,"floatShares":64483504,"shares":73052124,"eps":0.086673,"marketStatus":"休市中","marketStatusCode":7,"change":-0.03,"latestTime":"04-26 16:00:00 EDT","open":1.19,"high":1.22,"low":1.09,"amount":1078497.875236,"amplitude":0.110169,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.086673,"exchange":"AMEX","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1714377600000},"adr":0,"listingDate":829022400000,"adjPreClose":1.18,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":1.17,"preClose":1.18,"latestTime":"09:21 EDT","volume":35,"amount":40.949999999999996,"timestamp":1714137682670},"postHourTrading":{"tag":"盘后","latestPrice":1.15,"preClose":1.15,"latestTime":"16:20 EDT","volume":5179,"amount":5955.85,"timestamp":1714162800887},"volumeRatio":3.505501393888358},"requestUrl":"/m/hq/s/PLX/tweets","defaultTab":"tweets","newsList":[{"id":"2430204916","title":"Protalix Biotherapeutics, Inc. (De)盘中异动 早盘股价大跌5.93%报1.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430204916","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430204916?lang=zh_cn&edition=full","pubTime":"2024-04-26 23:25","pubTimestamp":1714145142,"startTime":"0","endTime":"0","summary":"北京时间2024年04月26日23时25分，Protalix Biotherapeutics, Inc. 股票出现异动，股价大幅下挫5.93%。Protalix Biotherapeutics, Inc. 股票所在的生物技术行业中，整体涨幅为0.13%。其相关个股中，Biodexa Pharmaceuticals Plc、Cassava Sciences Inc C/Wts 15/11/2024、Zura Bio Limited C/Wts 涨幅较大，Biodexa Pharmaceuticals Plc、Kintara Therapeutics, Inc.、Processa Pharmaceuticals, Inc.较为活跃，换手率分别为1242.02%、107.92%、42.94%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Biodexa Pharmaceuticals Plc、Cassava Sciences Inc C/Wts 15/11/2024，振幅分别为81.90%、73.12%、66.85%。Protalix Biotherapeutics, Inc. 公司简介：Protalix BioTherapeutics Inc是一家生物制药公司，专注于基于其专有的ProCellEx蛋白表达系统的重组治疗蛋白的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042623254287e843d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042623254287e843d0&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429143128","title":"Protalix Biotherapeutics, Inc. (De)盘中异动 下午盘快速拉升5.08%报1.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429143128","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429143128?lang=zh_cn&edition=full","pubTime":"2024-04-24 01:41","pubTimestamp":1713894113,"startTime":"0","endTime":"0","summary":"北京时间2024年04月24日01时41分，Protalix Biotherapeutics, Inc. 股票出现异动，股价大幅拉升5.08%。Protalix Biotherapeutics, Inc. 股票所在的生物技术行业中，整体涨幅为1.61%。Protalix Biotherapeutics, Inc. 公司简介：Protalix BioTherapeutics Inc是一家生物制药公司，专注于基于其专有的ProCellEx蛋白表达系统的重组治疗蛋白的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404240141537922b755&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404240141537922b755&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428349774","title":"Protalix Biotherapeutics, Inc. (De)盘中异动 早盘股价大涨5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428349774","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428349774?lang=zh_cn&edition=full","pubTime":"2024-04-17 21:55","pubTimestamp":1713362151,"startTime":"0","endTime":"0","summary":"北京时间2024年04月17日21时55分，Protalix Biotherapeutics, Inc. 股票出现异动，股价急速上涨5.23%。Protalix Biotherapeutics, Inc. 股票所在的生物技术行业中，整体涨幅为0.80%。Protalix Biotherapeutics, Inc. 公司简介：Protalix BioTherapeutics Inc是一家生物制药公司，专注于基于其专有的ProCellEx蛋白表达系统的重组治疗蛋白的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240417215551861e6b8f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240417215551861e6b8f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2425913736","title":"Protalix Biotherapeutics, Inc. (De)盘中异动 早盘大幅拉升5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2425913736","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2425913736?lang=zh_cn&edition=full","pubTime":"2024-04-08 21:48","pubTimestamp":1712584118,"startTime":"0","endTime":"0","summary":"北京时间2024年04月08日21时48分，Protalix Biotherapeutics, Inc. 股票出现异动，股价快速上涨5.13%。Protalix Biotherapeutics, Inc. 股票所在的生物技术行业中，整体跌幅为0.15%。其相关个股中，Longeveron Inc.、Apollomics Inc C/Wts 01/04/2028 、泰坦制药涨幅较大，Allarity Therapeutics, Inc.、Longeveron Inc.、Adial Pharmaceuticals, Inc较为活跃，换手率分别为656.70%、628.76%、53.25%，振幅较大的相关个股有Longeveron Inc.、泰坦制药、Cns Pharmaceuticals, Inc.，振幅分别为54.90%、19.42%、18.10%。Protalix Biotherapeutics, Inc. 公司简介：Protalix BioTherapeutics Inc是一家生物制药公司，专注于基于其专有的ProCellEx蛋白表达系统的重组治疗蛋白的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240408214838791f2cb2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240408214838791f2cb2&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419861943","title":"Protalix Biotherapeutics, Inc. (De)2023财年实现净利润8.31百万美元，同比增加155.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2419861943","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419861943?lang=zh_cn&edition=full","pubTime":"2024-03-15 15:24","pubTimestamp":1710487465,"startTime":"0","endTime":"0","summary":"12月31日，Protalix Biotherapeutics, Inc. 公布财报，公告显示公司2023财年净利润为8.31百万美元，同比增加155.66%；其中营业收入为65.49百万美元，同比增加37.47%，每股基本收益为0.12美元。从资产负债表来看，Protalix Biotherapeutics, Inc. 总负债50.87百万美元，其中短期债务21.66百万美元，资产负债比为1.66，流动比率为1.54。机构评级：截至2023年12月31日，当前有2家机构对Protalix Biotherapeutics, Inc. 目标价做出预测，其中目标均价为13.00美元，其中最低目标价为10.00美元，最高目标价为16.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403151540288b3680a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403151540288b3680a4&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419060456","title":"Protalix Biotherapeutics, Inc. (De)盘中异动 早盘股价大跌5.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2419060456","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419060456?lang=zh_cn&edition=full","pubTime":"2024-03-14 21:32","pubTimestamp":1710423142,"startTime":"0","endTime":"0","summary":"北京时间2024年03月14日21时32分，Protalix Biotherapeutics, Inc. 股票出现异动，股价急速下挫5.92%。Protalix Biotherapeutics, Inc. 股票所在的生物技术行业中，整体涨幅为0.51%。其相关个股中，知临集团、180 Life Sciences Corp C/Wts 07/11/2025、Nuvectis Pharma, Inc.涨幅较大，Novabay Pharmaceuticals, Inc.、知临集团、Gri Bio, Inc.较为活跃，换手率分别为116.13%、63.06%、58.54%，振幅较大的相关个股有知临集团、Renovorx, Inc.、Tracon Pharmaceuticals, Inc.，振幅分别为16.17%、14.40%、11.06%。Protalix Biotherapeutics, Inc. 公司简介：Protalix BioTherapeutics Inc是一家生物制药公司，专注于基于其专有的ProCellEx蛋白表达系统的重组治疗蛋白的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403142132237a4cb5b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403142132237a4cb5b1&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2416521234","title":"Protalix Biotherapeutics, Inc. (De)盘中异动 股价大涨5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2416521234","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2416521234?lang=zh_cn&edition=full","pubTime":"2024-03-01 00:05","pubTimestamp":1709222759,"startTime":"0","endTime":"0","summary":"北京时间2024年03月01日00时05分，Protalix Biotherapeutics, Inc. 股票出现异动，股价急速上涨5.19%。Protalix Biotherapeutics, Inc. 股票所在的生物技术行业中，整体跌幅为1.75%。其相关个股中，Enveric Biosciences, Inc.、Adial Pharmaceuticals, Inc、Codexis, Inc.涨幅较大，Enveric Biosciences, Inc.、Adial Pharmaceuticals, Inc、Scisparc Ltd.较为活跃，换手率分别为4363.91%、1389.67%、61.44%，振幅较大的相关个股有Carmell Corp C/Wts 12/07/2028 、Enveric Biosciences, Inc.、Ys Biopharma Co Ltd C/Wts 15/03/2028 ，振幅分别为164.60%、160.05%、95.99%。Protalix Biotherapeutics, Inc. 公司简介：Protalix BioTherapeutics Inc是一家生物制药公司，专注于基于其专有的ProCellEx蛋白表达系统的重组治疗蛋白的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403010006007a4833f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403010006007a4833f9&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2414830085","title":"Protalix Biotherapeutics Inc盘中异动 股价大涨5.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2414830085","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2414830085?lang=zh_cn&edition=full","pubTime":"2024-02-27 01:13","pubTimestamp":1708967616,"startTime":"0","endTime":"0","summary":"北京时间2024年02月27日01时13分，Protalix Biotherapeutics Inc股票出现波动，股价大幅拉升5.52%。Protalix Biotherapeutics Inc股票所在的生物技术行业中，整体涨幅为0.08%。其相关个股中，Zyversa Therapeutics Inc、Ocean Biomedical Inc、Ocean Biomedical Inc C/Wts 14/02/2028 涨幅较大，Zyversa Therapeutics Inc、Ocean Biomedical Inc、Neubase Therapeutics Inc较为活跃，换手率分别为1642.81%、203.37%、81.25%，振幅较大的相关个股有Zyversa Therapeutics Inc、Ocean Biomedical Inc、Seastar Medical Holding Corp C/Wts 28/10/2027 ，振幅分别为158.55%、85.99%、81.21%。Protalix Biotherapeutics Inc公司简介：Protalix BioTherapeutics Inc是一家生物制药公司，专注于基于其专有的ProCellEx蛋白表达系统的重组治疗蛋白的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402270113367a46f4ab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402270113367a46f4ab&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2411953890","title":"Protalix Biotherapeutics Inc盘中异动 下午盘股价大涨5.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2411953890","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2411953890?lang=zh_cn&edition=full","pubTime":"2024-02-15 03:04","pubTimestamp":1707937488,"startTime":"0","endTime":"0","summary":"北京时间2024年02月15日03时04分，Protalix Biotherapeutics Inc股票出现波动，股价快速上涨5.63%。Protalix Biotherapeutics Inc股票所在的生物技术行业中，整体涨幅为0.57%。其相关个股中，Engene Holdings Inc C/Wts 31/10/2028  Cl A、Telomir Pharmaceuticals Inc、Engene Holdings Inc涨幅较大，Adial Pharmaceuticals Inc、Kintara Therapeutics Inc、Azitra Inc较为活跃，换手率分别为108.98%、97.63%、51.19%，振幅较大的相关个股有Engene Holdings Inc C/Wts 31/10/2028  Cl A、Telomir Pharmaceuticals Inc、Greenwich Lifesciences Inc，振幅分别为224.76%、135.18%、61.73%。Protalix Biotherapeutics Inc公司简介：Protalix BioTherapeutics Inc是一家生物制药公司，专注于基于其专有的ProCellEx蛋白表达系统的重组治疗蛋白的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024021503044887e701b3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024021503044887e701b3&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2405715461","title":"Protalix Biotherapeutics Inc盘中异动 快速跳水5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2405715461","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2405715461?lang=zh_cn&edition=full","pubTime":"2024-01-24 00:24","pubTimestamp":1706027092,"startTime":"0","endTime":"0","summary":"北京时间2024年01月24日00时24分，Protalix Biotherapeutics Inc股票出现异动，股价急速下跌5.10%。Protalix Biotherapeutics Inc股票所在的生物技术行业中，整体跌幅为0.19%。其相关个股中，Ensysce Biosciences Inc、Tc Biopharm  Plc C/Wts 10/02/2028 、Outlook Therapeutics Inc涨幅较大，Ensysce Biosciences Inc、Transcode Therapeutics Inc、Kintara Therapeutics Inc较为活跃，换手率分别为932.90%、149.04%、35.95%，振幅较大的相关个股有Ys Biopharma Co Ltd C/Wts 15/03/2028 、Ocean Biomedical Inc C/Wts 14/02/2028 、Revelation Biosciences Inc，振幅分别为70.54%、53.20%、42.14%。Protalix Biotherapeutics Inc公司简介：Protalix BioTherapeutics Inc是一家生物制药公司，专注于基于其专有的ProCellEx蛋白表达系统的重组治疗蛋白的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401240024527a3db0b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401240024527a3db0b8&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2402089364","title":"Protalix Biotherapeutics Inc盘中异动 快速跳水5.56%报1.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2402089364","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2402089364?lang=zh_cn&edition=full","pubTime":"2024-01-12 00:42","pubTimestamp":1704991330,"startTime":"0","endTime":"0","summary":"北京时间2024年01月12日00时42分，Protalix Biotherapeutics Inc股票出现异动，股价大幅跳水5.56%。截至发稿，该股报1.62美元/股，成交量7.8469万股，换手率0.11%，振幅4.06%。Protalix Biotherapeutics Inc股票所在的生物技术行业中，整体跌幅为0.61%。Protalix Biotherapeutics Inc公司简介：Protalix BioTherapeutics Inc是一家生物制药公司，专注于基于其专有的ProCellEx蛋白表达系统的重组治疗蛋白的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240112004210790827e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240112004210790827e1&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2394247287","title":"Protalix Biotherapeutics Inc盘中异动 早盘快速拉升5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2394247287","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2394247287?lang=zh_cn&edition=full","pubTime":"2023-12-26 23:30","pubTimestamp":1703604638,"startTime":"0","endTime":"0","summary":"北京时间2023年12月26日23时30分，Protalix Biotherapeutics Inc股票出现波动，股价快速上涨5.00%。Protalix Biotherapeutics Inc股票所在的生物技术行业中，整体涨幅为0.24%。其相关个股中，Rayzebio Inc、Apollomics Inc C/Wts 01/04/2028 、亘喜生物涨幅较大，60 Degrees Pharmaceuticals Inc、Brainstrom Cell Therapeutics、Onconetix Inc较为活跃，换手率分别为223.31%、37.04%、16.84%，振幅较大的相关个股有Apollomics Inc C/Wts 01/04/2028 、Celularity Inc C/Wts 16/07/2026 、60 Degrees Pharmaceuticals Inc，振幅分别为74.00%、61.58%、34.38%。Protalix Biotherapeutics Inc公司简介：Protalix BioTherapeutics Inc是一家生物制药公司，专注于基于其专有的ProCellEx蛋白表达系统的重组治疗蛋白的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023122623303887e61b2c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023122623303887e61b2c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2393419138","title":"Protalix Biotherapeutics Inc盘中异动 股价大涨5.17%报1.83美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2393419138","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2393419138?lang=zh_cn&edition=full","pubTime":"2023-12-23 01:01","pubTimestamp":1703264511,"startTime":"0","endTime":"0","summary":"北京时间2023年12月23日01时01分，Protalix Biotherapeutics Inc股票出现异动，股价急速拉升5.17%。Protalix Biotherapeutics Inc股票所在的生物技术行业中，整体涨幅为1.61%。其相关个股中，Karuna Therapeutics Inc、Neumora Therapeutics Inc、Puretech Health Plc涨幅较大，Panbela Therapeutics Inc、Senti Biosciences Inc、Aditxt Inc较为活跃，换手率分别为74.93%、59.50%、23.52%，振幅较大的相关个股有Geovax Labs Inc C/Wts 29/09/2025、Neumora Therapeutics Inc、Panbela Therapeutics Inc，振幅分别为75.00%、32.91%、30.82%。Protalix Biotherapeutics Inc公司简介：Protalix BioTherapeutics Inc是一家生物制药公司，专注于基于其专有的ProCellEx蛋白表达系统的重组治疗蛋白的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023122301015187e61556&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023122301015187e61556&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2392799204","title":"Protalix Biotherapeutics Inc盘中异动 股价大涨5.23%报1.81美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2392799204","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2392799204?lang=zh_cn&edition=full","pubTime":"2023-12-19 00:29","pubTimestamp":1702916958,"startTime":"0","endTime":"0","summary":"北京时间2023年12月19日00时29分，Protalix Biotherapeutics Inc股票出现异动，股价快速上涨5.23%。截至发稿，该股报1.81美元/股，成交量37.2104万股，换手率0.51%，振幅5.81%。Protalix Biotherapeutics Inc股票所在的生物技术行业中，整体跌幅为0.50%。Protalix Biotherapeutics Inc公司简介：Protalix BioTherapeutics Inc是一家生物制药公司，专注于基于其专有的ProCellEx蛋白表达系统的重组治疗蛋白的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202312190029187a343f17&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202312190029187a343f17&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2391980855","title":"Protalix Biotherapeutics Inc盘中异动 急速上涨5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2391980855","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2391980855?lang=zh_cn&edition=full","pubTime":"2023-12-14 01:16","pubTimestamp":1702487808,"startTime":"0","endTime":"0","summary":"北京时间2023年12月14日01时16分，Protalix Biotherapeutics Inc股票出现波动，股价急速上涨5.06%。Protalix Biotherapeutics Inc股票所在的生物技术行业中，整体涨幅为2.78%。其相关个股中，Protagenic Therapeutics Inc C/Wts 29/04/2026 、Shattuck Labs Inc、C4 Therapeutics Inc涨幅较大，Scisparc Ltd、C4 Therapeutics Inc、Aditxt Inc较为活跃，换手率分别为977.60%、274.13%、250.28%，振幅较大的相关个股有Avalo Therapeutics Inc、Tc Biopharm  Plc C/Wts 10/02/2028 、Shattuck Labs Inc，振幅分别为116.71%、110.74%、82.93%。Protalix Biotherapeutics Inc公司简介：Protalix BioTherapeutics Inc是一家生物制药公司，专注于基于其专有的ProCellEx蛋白表达系统的重组治疗蛋白的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023121401164884767307&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023121401164884767307&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2389007866","title":"Protalix Biotherapeutics Inc盘中异动 大幅拉升5.03%报1.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2389007866","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2389007866?lang=zh_cn&edition=full","pubTime":"2023-12-08 00:12","pubTimestamp":1701965555,"startTime":"0","endTime":"0","summary":"北京时间2023年12月08日00时12分，Protalix Biotherapeutics Inc股票出现波动，股价大幅拉升5.03%。截至发稿，该股报1.67美元/股，成交量16.2238万股，换手率0.22%，振幅3.77%。Protalix Biotherapeutics Inc股票所在的生物技术行业中，整体涨幅为0.20%。Protalix Biotherapeutics Inc公司简介：Protalix BioTherapeutics Inc是一家生物制药公司，专注于基于其专有的ProCellEx蛋白表达系统的重组治疗蛋白的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231208001235830b4caa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231208001235830b4caa&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.protalix.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":-0.08},{"period":"3month","weight":-0.223},{"period":"6month","weight":-0.1958},{"period":"1year","weight":-0.5693},{"period":"ytd","weight":-0.3539}],"compareEarnings":[{"period":"1week","weight":0.0265},{"period":"1month","weight":-0.0285},{"period":"3month","weight":0.0428},{"period":"6month","weight":0.2376},{"period":"1year","weight":0.2324},{"period":"ytd","weight":0.0693}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Protalix Biotherapeutics, Inc.最初于1992年4月在佛罗里达州注册成立，并于2016年3月在特拉华州重新注册成立。该公司是一家生物制药公司，专注于开发、生产和商业化由专有的ProCellEx植物细胞蛋白表达系统生产的重组治疗蛋白。该公司是第一家也是唯一一家获得FDA批准的通过植物细胞表达悬浮蛋白生产的公司。该公司独特的表达系统代表了一种以工业规模开发重组蛋白的新方法。该公司的战略重点是开发主要通过ProCellEx生产的定制复杂重组治疗性蛋白质，同时在生产前和生产后对蛋白质进行基因工程和化学修饰。该公司打算通过改进治疗蛋白的生物学特性（例如，糖基化、半衰期、免疫原性），进行此类工程设计和修改，以提供额外的临床益处。","yearOnYearQuotes":[{"month":1,"riseRate":0.705882,"avgChangeRate":0.101027},{"month":2,"riseRate":0.411765,"avgChangeRate":0.04937},{"month":3,"riseRate":0.294118,"avgChangeRate":-0.041326},{"month":4,"riseRate":0.555556,"avgChangeRate":0.048935},{"month":5,"riseRate":0.235294,"avgChangeRate":-0.027667},{"month":6,"riseRate":0.411765,"avgChangeRate":-0.038226},{"month":7,"riseRate":0.411765,"avgChangeRate":-0.045891},{"month":8,"riseRate":0.352941,"avgChangeRate":-0.009879},{"month":9,"riseRate":0.352941,"avgChangeRate":0.026985},{"month":10,"riseRate":0.352941,"avgChangeRate":-0.071025},{"month":11,"riseRate":0.352941,"avgChangeRate":-0.022185},{"month":12,"riseRate":0.352941,"avgChangeRate":-0.0158}],"exchange":"AMEX","name":"Protalix BioTherapeutics Inc","nameEN":"Protalix BioTherapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Protalix BioTherapeutics Inc(PLX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Protalix BioTherapeutics Inc(PLX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Protalix BioTherapeutics Inc,PLX,Protalix BioTherapeutics Inc股票,Protalix BioTherapeutics Inc股票老虎,Protalix BioTherapeutics Inc股票老虎国际,Protalix BioTherapeutics Inc行情,Protalix BioTherapeutics Inc股票行情,Protalix BioTherapeutics Inc股价,Protalix BioTherapeutics Inc股市,Protalix BioTherapeutics Inc股票价格,Protalix BioTherapeutics Inc股票交易,Protalix BioTherapeutics Inc股票购买,Protalix BioTherapeutics Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Protalix BioTherapeutics Inc(PLX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Protalix BioTherapeutics Inc(PLX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况